Routine Sample Size for a Retest Procedure

November 2, 2003
Jeffrey D. Hofer

Jeffrey D. Hofer is a senior statistician in Global Statistical Sciences at Eli Lilly and Company.

Pharmaceutical Technology, Pharmaceutical Technology-11-02-2003, Volume 27, Issue 11

This article discusses a straightforward approach that scientists may use to descide how many nonsuspect restest results are required to provide sufficient evidence to overcome an initial suspect result.